Internet Archive Scholar

Pituitary carcinoma as a rare cause of liver metastases successfully treated with temozolomide

Maria Stelmachowska-Banaś, Maria Maksymowicz, Agnieszka Kolasińska-Ćwikła, Grzegorz Zieliński, Márta Korbonits, Wojciech Zgliczyński
2021

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (327.8 kB)
https://web.archive.org/web/20220521102030/https://qmro.qmul.ac.uk/xmlui/bitstream/handle/123456789/76099/Korbonits%20Pituitary%20carcinoma%20as%20a%20rare%20cause%20of%20liver%20metastases%20successfully%20treated%20with%20temozolomide.%202021%20Accepted.pdf;jsessionid=FF33291346B0D488B23364966A6F73ED?sequence=2

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

Pituitary carcinoma (PC) is an extremely rare malignancy accounting for 0.1-0.2% of all pituitary neuroendocrine tumours (PitNETs). PC diagnosis requires either intracranial or distant metastases which appear on average 9 years (range 0-31) after the first presentation of PitNET [1, 2] . The prevalence of PC could be underestimated, as the identification of distant
doi:10.20452/pamw.16178 pmid:34935323 fatcat:fx4qo5numvcvxelyfnqtnsm5ba
Citation

Maria Stelmachowska-Banaś, Maria Maksymowicz, Agnieszka Kolasińska-Ćwikła, Grzegorz Zieliński, Márta Korbonits, Wojciech Zgliczyński. "Pituitary carcinoma as a rare cause of liver metastases successfully treated with temozolomide." (2021)